Pacific region influenza surveillance for oseltamivir resistance

Journal of Clinical Virology

Volumn 54, Issue 1, 2012, Pages 73-75

  Miller, Heather B ^a   Gose, Remedios B ^a   Nagata, Mark T ^a   Sciulli, Rebecca H ^a   Whelen, A Christian ^a,b  

^a State Laboratories Division   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

Influenza surveillance; Oseltamivir resistance; Pacific; Pyrosequencing

Indexed keywords

OSELTAMIVIR; SIALIDASE;

ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; ECONOMIC ASPECT; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PYROSEQUENCING; RNA EXTRACTION; TRAVEL; UNITED STATES; VACCINATION;

AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HAWAII; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MICROBIAL SENSITIVITY TESTS; MUTANT PROTEINS; MUTATION, MISSENSE; NEURAMINIDASE; OSELTAMIVIR; PACIFIC ISLANDS; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL PROTEINS;

EID: 84861852071     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.01.007     Document Type: Article

References (30)

1. Palau Office of Planning and Statistics. Imigration and Tourist Statistics: visitor arrivals by country of residence and Purpose of Visit-2008 (Latest Year). 2008 [Updated 24 Jul 2009; Cited 15 Aug 2011]. Available at: http://www.palaugov.net/stats/PalauStats/Tourism/tourism.htm.
2. American Samoa Department of Commerce [home page on the Internet]. 2008 [Updated 5 Aug 2009; cited 15 Aug 2011]. Available at: http://www.spc.int/prism/country/as/stats/.
3. Statistical Unit, Department of Economic Affairs International Visitor Arrivals Federated States of Micronesia 2006, [Updated Mar 2006; Cited 15 Aug 2011]. Available at: http://www.spc.int/prism/country/fm/stats/Publications/Quarterly/VAs/16IVA_Oct05-Dec06.pdf.
4. Guam Visitors Bureau. FY 2008 Financial Highlights 2008 [Updated 13 Apr 2009; Cited 15 Aug 2011]. Available at: http://www.guamopa.org/docs/GVBhighlights08.pdf.
5. Department of Commerce, Commonwealth of the Northern Mariana Islands Economic indicator: a quarterly report July-December 2009 [Updated 2010; Cited 15 Aug 2011] 2010, Available at:. http://commerce.gov.mp/wp-content/uploads/2010/08/EI_2009.3.4.pdf.
6. Marshal Islands Visitor's Authority; RMI Economic Policy, Planning and Statistics Office. Tourism Statistics. 2005 [Updated 2007; Cited 15 Aug 2011]. Available at: http://www.spc.int/prism/Country/MH/stats/Tourism/Vis_Ctyresidence.htm.
7. Department of Business, Economic Development & Tourism, State of Hawaii. Annual Visitors Research Report. 2009 [Updated 10 Oct 2010; cited 15 Aug 2011]. Available at: http://hawaii.gov/dbedt/info/visitor-stats/visitor-research/2009-annual-visitor.pdf.
8. Center for Disease Control and Prevention. Seasonal Influenza. [Update 6 Jul 2011; Cited 15 Aug 2011]. Available at: http://www.cdc.gov/flu/about/qa/disease.htm.
9. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005, 353:1363-1373.
10. Centers for Disease Control and Prevention High levels of adamantane resistance among influenza A(H3N2) viruses and interim guidelines for use of antiviral agents-United States, 2005-06 influenza season. Morb Mortal Wkly Rep 2006, 20(January (55)):1-2. (Dispatch).
11. Centers for Disease Control and Prevention Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. Morb Mortal Wkly Rep 2009, 1(May (58)):433-435.
12. Centers for Disease Control and Prevention Influenza activity-United States and worldwide, 2007-08 season. Morb Mortal Wkly Rep 2008, 57(25):692-697.
13. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992, 56:152-179.
14. van den Dool C., Hak E., Bonten M.J., Wallinga J. A model-based assessment of oseltamivir prophylaxis strategies to prevent influenza in nursing homes. Emerg Infect Dis 2009, 15:1547-1555.
15. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360:2605-2615. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team.
16. Deyde V.M., Sheu T.G., Trujillo A.A., Okomo-Adhiambo M., Garten R., Klimov A.I., et al. Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob Agents Chemother 2010, 54:1102-1110.
17. Dharan N.J., Gubareva L.V., Meyer J.J., Okomo-Adhiambo M., McClinton R.C., Marshall S.A., et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 2009, 301:1034-1041.
18. Matsuzaki Y., Mizuta K., Aoki Y., Suto A., Abiko C., Sanjoh K., et al. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata Japan and the clinical effectiveness of oseltamivir and zanamivir. Virol J 2010, 7:53.
19. Tramontana A., George B., Hurt A.C., Doyle J.S., Langan K., Reid A.B., et al. Oseltamivir Resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus. Australia EID 2010, 16(7):1068075.
20. New South Wales Health. Influenza weekly epidemiology report. 20-26 Aug 2011 [Updated 26 Aug 2011; Cited 21 Oct 2011]. Available at: http://www.health.nsw.gov.au/resources/publichealth/infectious/influenza/pdf/week_ending_26082011.pdf.
21. Hurt A.C., Hardie K., Wilson N., Deng Y.M., Osbourn M., Gehrig N., et al. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N Engl J Med 2011, 365:2541-2542.
22. Centers for Disease Control and Prevention (CDC), National Center for Immunizations and Respiratory Diseases (NCIRD), Virus Surveillance and Diagnosis Branch (VSDB), Molecular Epidemiology Team (MET) Pyrosequencing protocol for detection of 275Y mutations in pandemic H1N1 viruses in the PyroMark™ Q96 ID platform 2009.
23. Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD), Virus Surveillance and Diagnosis Branch (VSDB), Molecular Epidemiology Team (MET) Pyrosequencing protocol for detection of 275Y mutation in pandemic H1N1 viruses in the PyroMark™ Q96 ID platform. No: SHL-001 2010.
24. World Health Organization. Pandemic (H1N1) 2009: Antiviral drug resistance. 2009 [Updated 22 Dec 2009; Cited 15 Aug 2011]. Available at: http://www.who.int/csr/disease/swineflu/frequently_asked_questions/antivirals/resistance/en/index.html.
25. World Health Organization. Update on oseltamivir resistance to influenza A (H1N1) 2009 viruses. 23 Aug-7 Sep 2011 [Updated 07 Sep 2011; Cited 21 Oct 2011]. Available at: http://www.who.int/influenza/surveillance_monitoring/updates/2011_09_09_weekly_web_update_oseltamivir_resistance.pdf.
26. Hurt A.C., Deng Y.M., Ernest J., Caldwell N., Leang L., Iannello P., et al. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1)2009 pandemic in the Asia-Pacific region, March 2009 to March 2010. Euro Surveill 2011, 16(3). pii=19770. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19770.
27. Chen H., Cheung C.L., Tai H., Zhao P., Chan J.F.W., Cheng V.C.C., et al. Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong China. Emerg Infect Dis 2009, 15:1970-1972.
28. Personal communication with Executive Director of the Pacific Island Health Officers Association; 2011.
29. Centers for Disease Control and Prevention Evaluation of rapid influenza diagnostic tests for detection of novel Influenza A (H1N1) Virus-United States, 2009. Morb Mortal Wkly Rep 2009, 58(30):826-829.
30. Centers for Disease Control and Prevention Update: influenza activity-United States and worldwide, May 20-September 15, 2007. Morb Mortal Wkly Rep 2007, 56(38):1001-1003.